Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy ROCHELLE PARK, N.J., May 14, 2009 (GLOBE NEWSWIRE) -- Asubio Pharmaceuticals, Inc. will present new data on the efficacy and safety of Piclozotan in improving both dyskinesia and OFF time in...

Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy Asubio Pharmaceuticals, Inc. to Present Data At the Movement Disorder Society's 13th International Congress of Parkinson's Disease and Movement Disorders ROCHELLE PARK, N.J., May 14, 2009 (GLOBE...

Study Shows Carperitide Significantly Reduces Cardiac Death and Improves Outcomes in Acute Myocardial Infarction ROCHELLE PARK, N.J., Jan. 15, 2008 (PRIME NEWSWIRE) -- According to an independent study published in the Lancet in October 2007, carperitide (human atrial natriuretic peptide) significantly reduced...